Control Bionics' US Business Logs Record Revenue in Fiscal Q2

MT Newswires Live

2025/02/03

Control Bionics' (ASX:CBL) US business reported record revenue of nearly $1 million in the fiscal second quarter ended December 2024, according to a Jan. 31 filing with the Australian bourse.

Cash receipts surpassed AU$1.4 million, representing an almost 30% year-on-year rise on the back of strong US sales and improving National Disability and Insurance Scheme approvals, per the filing.

Elsewhere, the medical device company logged its first sales in the UK and Ireland following the Smart Box distribution agreement.

Control Bionics reported net cash outflows of AU$1.7 million for the fiscal Q2.

The company said it is "positioned for strong growth" in the second half of the fiscal year.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2508169901"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2508169901\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2508169901?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-02-03 11:03","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2508169901","market":"us","top_or_hot":-1,"title":"Control Bionics' US Business Logs Record Revenue in Fiscal Q2","media":"MT Newswires Live","content":"<html><body><p> Control Bionics' (ASX:CBL) US business reported record revenue of nearly $1 million in the fiscal second quarter ended December 2024, according to a Jan. 31 filing with the Australian bourse.</p><p>Cash receipts surpassed AU$1.4 million, representing an almost 30% year-on-year rise on the back of strong US sales and improving National Disability and Insurance Scheme approvals, per the filing.</p><p>Elsewhere, the medical device company logged its first sales in the UK and Ireland following the Smart Box distribution agreement.</p><p>Control Bionics reported net cash outflows of AU$1.7 million for the fiscal Q2.</p><p>The company said it is \"positioned for strong growth\" in the second half of the fiscal year.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Control Bionics' US Business Logs Record Revenue in Fiscal Q2</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nControl Bionics' US Business Logs Record Revenue in Fiscal Q2\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time smaller\">2025-02-03 11:03</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html><body><p> Control Bionics' (ASX:CBL) US business reported record revenue of nearly $1 million in the fiscal second quarter ended December 2024, according to a Jan. 31 filing with the Australian bourse.</p><p>Cash receipts surpassed AU$1.4 million, representing an almost 30% year-on-year rise on the back of strong US sales and improving National Disability and Insurance Scheme approvals, per the filing.</p><p>Elsewhere, the medical device company logged its first sales in the UK and Ireland following the Smart Box distribution agreement.</p><p>Control Bionics reported net cash outflows of AU$1.7 million for the fiscal Q2.</p><p>The company said it is \"positioned for strong growth\" in the second half of the fiscal year.</p></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CBL.AU","symbol_name":"Control Bionics Ltd","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2508169901","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2508169901","pubTimestamp":1738551832,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Control Bionics'  US business reported record revenue of nearly $1 million in the fiscal second quarter ended December 2024, according to a Jan. 31 filing with the Australian bourse.Cash receipts surpassed AU$1.4 million, representing an almost 30% year-on-year rise on the back of strong US sales and improving National Disability and Insurance Scheme approvals, per the filing.Elsewhere, the medical device company logged its first sales in the UK and Ireland following the Smart Box distribution agreement.Control Bionics reported net cash outflows of AU$1.7 million for the fiscal Q2.The company said it is \"positioned for strong growth\" in the second half of the fiscal year.","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"CBL.AU":"Control Bionics Ltd"},"translate_title":"Control Bionics美国业务第二财季收入创历史新高","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CBL.AU":0.9},"content_text":"Control Bionics' (ASX:CBL) US business reported record revenue of nearly $1 million in the fiscal second quarter ended December 2024, according to a Jan. 31 filing with the Australian bourse.Cash receipts surpassed AU$1.4 million, representing an almost 30% year-on-year rise on the back of strong US sales and improving National Disability and Insurance Scheme approvals, per the filing.Elsewhere, the medical device company logged its first sales in the UK and Ireland following the Smart Box distribution agreement.Control Bionics reported net cash outflows of AU$1.7 million for the fiscal Q2.The company said it is \"positioned for strong growth\" in the second half of the fiscal year.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}